Price target
96.620.000.00%
The 26 analysts offering 1 year price forecasts for BMRN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings to BMRN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BMRN EPS for the last quarter is 0.55 USD despite the estimation of 0.53 USD. In the next quarter EPS is expected to reach 0.55 USD. Track more of BioMarin Pharmaceutical Inc. financials and stay on top of what is up with the company.
In the next quarter BioMarin Pharmaceutical Inc. revenue is expected to reach 712.07 M USD. Check out BioMarin Pharmaceutical Inc. revenue and earnings and make informed decisions.
According to analysts, BMRN price target is 96.62 USD with a max estimate of 127.00 USD and a min estimate of 65.00 USD. Check if this forecast comes true in a year, meanwhile watch BioMarin Pharmaceutical Inc. stock price chart and keep track of the current situation with BMRN news and stock market news.
We've gathered opinions of 30 analysts rating BMRN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.